DECN Readies GenViro! Covid-19 Swift Kits for FDA Testing
Decision Diagnostics is readying testing samples of its GenViro! Covid-19 Swift Kits for testing in the US market and additional testing internationally.
Read MorePosted by Melanie Hamilton-Basich | Jul 29, 2020 | Covid 19, Immunoassay Reagents & test Kits |
Decision Diagnostics is readying testing samples of its GenViro! Covid-19 Swift Kits for testing in the US market and additional testing internationally.
Read MorePosted by Melanie Hamilton-Basich | Jul 29, 2020 | Covid 19, Uncategorized |
Shipments of covid-19 molecular diagnostic tests reached 1 million per day for the week ending July 24, based on AdvaMed National Testing Registry data.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Compliance, Covid 19 |
On July 29, the FDA will host a virtual Town Hall for clinical labs and commercial manufacturers involved in developing diagnostic tests for SARS-CoV-2.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Company News |
The CDC has chosen BioReference Laboratories as one of the antibody testing and service providers for the national covid-19 serological survey.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Molecular Diagnostics |
A paper published in npj Genomic Medicine demonstrates the identification of more reportable CNVs with OGT’s CytoSure v3 versus traditional array design.
Read More